Appeal for Increasing the Impact of Pharmacovigilance Agnes C. Kant Editorial 20 December 2023 Pages: 113 - 116
The Unseen Hand: AI-Based Prescribing Decision Support Tools and the Evaluation of Drug Safety and Effectiveness Harriet DickinsonDana Y. Teltschthe Actionable AI group Current Opinion 29 November 2023 Pages: 117 - 123
SGLT2 Inhibitor Use and Risk of Breast Cancer Among Adult Women with Type 2 Diabetes Fengge WangMichael HendryxJuhua Luo Original Research Article 09 December 2023 Pages: 125 - 133
Effectiveness and Respiratory Adverse Events Following Inactivated and mRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based Study Simon Xiwen QinFranco Wing Tak ChengEsther Wai Yin Chan Original Research Article Open access 12 December 2023 Pages: 135 - 146
Enhancing Pharmacovigilance in Côte d'Ivoire: Impact of GSK’s Training and Mentoring Pilot Project in the Abidjan Region Yolanda Guerra MendozaViviane JusotMamadou Kamagaté Original Research Article Open access 15 November 2023 Pages: 147 - 159
A Descriptive Analysis of Adverse Event Reports from the Quebec Cannabis Registry Yasmina HachemYola MorideAntonio Vigano Original Research Article 23 November 2023 Pages: 161 - 171
Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing Guojun DongAndrew BateMaurizio Sessa Original Research Article Open access 07 December 2023 Pages: 173 - 182
Implementation of a Taxonomy-Based Framework for the Selection of Appropriate Drugs and Outcomes for Real-World Data Signal Detection Studies Astrid CosteAngel YS WongIan J. Douglas Original Research Article Open access 13 December 2023 Pages: 183 - 192
Correction to: Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media Cristina MicaleSu GolderGraciela Gonzalez-Hernandez Correction 17 January 2024 Pages: 193 - 193